摘要
目的 分析某院2018-2021年VTE患者例数与死亡情况，并对患者一般资料及住院病情与罹患VTE的关系进行分析。方法 依据某三甲医院2018-2021年出院患者病案首页信息，统计2018-2021年DVT、PE患者占比及死亡占比，不同年龄段DVT、PE发生率，并采用c2检验分析患者一般资料与VTE的关系。结果 2018-2021年DVT、PE患者占比和死亡占比均呈上升趋势，不论男女，DVT、PE发生率均随着年龄增大而增加。年龄、婚姻状况、职业、民族、血型和医疗付费方式是DVT发生的影响因素，性别、年龄、婚姻状况、职业、民族和医疗付费方式是PE发生的影响因素。结论 医院VTE患者占比及死亡占比逐年增加，医护人员应根据影响因素针对性地预防和干预VTE。
关键词： 静脉血栓栓塞症；发生情况；防治措施
Abstract
Objective To analyze the number of cases and death of VTE patients in a hospital from 2018 to 2021, and to analyze the relationship between the general information of patients, hospitalization conditions and VTE. Methods According to the information on the first page of the medical records of discharged patients from 2018 to 2021, the proportion of DVT and PE patients and the death proportion from 2018 to 2021 were analyzed. The incidence of DVT and PE in different age groups was analyzed, and the relationship between general data and VTE was analyzed by Chi-square Test. Results From 2018 to 2021, the proportion of DVT and PE patients and the proportion of deaths showed an increasing trend, and the incidence of DVT and PE increased with the increase of age in both men and women. Age, marital status, occupation, nationality, blood type and medical payment method were the influencing factors of DVT, while gender, age, marital status, occupation, nationality and medical payment method were the influencing factors of PE. Conclusion The proportion of VTE patients and deaths in hospitals increased by years. Medical staff should prevent and intervene VTE according to the influencing factors.
Key words： Venous Thromboembolism; occurrence; prevention measures
参考文献 References
[1] Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality [J]. Thromb Haemost, 2007, 98(4): 756-764.
[2] Heit A. The epidemiology of venous thromboembolism in the community: implications for prevention and manage -ment [J]. Thromb Thrombolysis, 2006, 21(1): 23 -29.
[3] ZHANG Z, LEI J, SHAO X,et al. Trends in hospitalization andin-hospital mortality from VTE, 2007 to 2016, in China[J]. CHEST, 2019,155(2):342-353.
[4] MOORES L K, TRITSCHLER T, BROSNAHAN S,et al. Prevention, diagnosis, and treatment of VTE in patients withcoronavirus disease 2019: CHEST Guideline and Expert PanelReport [J].Chest, 2020,158(3):1143-1163.
[5] KEARON C, AKL E A, COMEROTA A J,et al. Antithrombotictherapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(2 Suppl): e419S -496S.
[6] Wolberg AS, Rosendaal FR, Weitz JI,et al. Venous thrombosis[J].Nat Rev Dis Primers, 2015,1:15006.
[7] ISTH Steering Committee for World Thrombosis Day. Thrombosis:a major contributor to the global disease burden [J].J Thromb Haemost, 2014,12(10):1580 -1590.
[8] Cheuk BL, Cheung GC, Cheng SW. Epidemiology of venousthrom boembolism in a Chinese population[J].Br J Surg, 2004, 91(4):424 -428.
[9] 中华医学会血栓栓塞性疾病防治委员会.医院内静脉血栓栓塞症预防与管理建议[J].中华医学杂志,2012,92 (40):2816 -2819.
[10] 翟振国,王辰.建立和完善医院内静脉血栓栓塞症的防治管理体系[J].中华医学杂志,2015,95(30):2417 -2418.